AZN AstraZeneca PLC

NYSE
$186.85

AstraZeneca PLC (AZN) is expected to report earnings on January 29, 2027, before the market open. The consensus earnings estimate is $2.23 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +1.8% since its last earnings release on October 30, 2026.

AstraZeneca PLC Beat Consensus Estimates, Reaffirms
Friday, October 30, 2026 · 7:00 AM ET
Earnings Date
4th Quarter, Dec 2026
Jan 29
Friday · 7:00 AM ET
Earnings Whisper
-
vs $2.23
Rev est $16.56B
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $186.64

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About AstraZeneca PLC

AstraZeneca PLC is a biopharmaceutical company. It is engaged in the discovery and development of new products, which are then manufactured, marketed and sold.

Sector

Healthcare

Industry

Drug Manufacturers / Major

Held By 2 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.